Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Coronary Stents Market Outlook

The global coronary stents market size was valued at USD 9.8 billion in 2023, driven by the increasing incidence of coronary stents among people across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 16 billion by 2032.

Coronary Stents: Introduction

Coronary stents are the metallic mesh tubes that are used to keep the coronary arteries open followed by an angioplasty, a procedure which is performed to open the narrowed or blocked blood vessels responsible for the blood supply by removing plaque build-up. This plaque usually accumulates fat and cholesterol inside the artery wall. These blocked vessels are usually referred to as coronary arteries.

Global Coronary Stents Market Analysis

The market growth is driven by the increased prevalence of cardiovascular disease (CVD) and the increase in the number of angioplasties. CVD remains the leading cause of mortality for men and women worldwide. Each year around 60 million people across the world develop heart or circulatory disease.

The coronary stents market growth is further driven by factors such as approvals by the U.S. Food and Drug Administration (FDA) for new equipment with substantial potential to treat the condition effectively and reduce the burden globally. For example, the BioFreedom Drug Coated Coronary Stent (DCS) System – P190020 (drug eluting stent) from Biosensors International, received FDA approval this year. The BioFreedom Drug Coated Coronary Stent System is targeted to treat coronary arteries caused by coronary artery disease. Coronary arteries are blood vessels that have been narrowed due to the accumulation of plaque in the inside of the arteries. The approval of such innovative equipment increases the demand for innovations in the market and facilitates the healthcare provider to perform angioplasty procedures with ease, further bolstering the global coronary stents market demand.

The market growth is further attributed to the mergers and acquisitions by market key players exemplified by the acquisition of Taewoong Medical, South Korean stent maker by Olympus, Japanese medical device maker for about USD 370 million as their second biggest acquisition of all times. Such acquisitions mark an achievement in Olympus’s portfolio as they will now be expected to have access to the sources of Taewoong Medical which is expected to boost the market growth further.

Global Coronary Stents Market Segmentations

Market Breakup by Type

  • Bare Metal Stents
  • Drug Eluting Stents
  • Bioresorbable Vascular Scaffold

Market Breakup by End User

  • Hospitals
  • Eye Clinics

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Coronary Stents Market Overview

The market is significantly driven by the increasing prevalence of coronary heart disease globally. The increasing prevalence of coronary heart disease is contributing to the increased incidence of angioplasties in the market as well. Furthermore, the market's key players are focused on developing technologically advanced stents to treat the medical condition with minimally invasive procedures. The increasing preference of people for minimally invasive procedures is a major factor contributing to the global coronary stents market share.

Geographically, North America has been leading the market growth and is expected to lead in the forecast period. The market is further driven by the increased prevalence as according to the Centers for Disease Control and Prevention, Heart Diseases claim a death every 33 seconds in the United States. The market is further driven by the strategic initiatives by the governments in spreading awareness about coronary artery and heart diseases.

Global Coronary Stents Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Abbott
  • Medtronic Plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • C. R. Bard, Inc.
  • Metabiomics
  • MicroPort Scientific Corporation

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • End User
  • Region
Breakup by Type
  • Bare Metal Stents
  • Drug Eluting Stents
  • Bioresorbable Vascular Scaffold
Breakup by End User
  • Hospitals
  • Eye Clinics
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott
  • Medtronic Plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • C. R. Bard, Inc.
  • Metabiomics
  • MicroPort Scientific Corporation

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 9.8 billion in 2023, driven by the increased incidence of angioplasty.

The market is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 and is likely to reach a market value of USD 16 billion by 2032.

The increasing prevalence of coronary heart disease, along with increasing research and development activities, are the key factors bolstering the market growth.

The rising number of FDA approvals for the development of innovative and more effective stents is a major trend influencing market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

The types can be categorised into bare metal stents, drug eluting stents, and bioresorbable vascular scaffolds. 

End users in the market are hospitals and eye clinics.

Key players involved in the market are Abbott, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, C. R. Bard, Inc., Metabiomics, and MicroPort Scientific Corporation.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124